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Gene delivery holds great potential in treatment of genetic and acquired human diseases. 
The success of non-viral gene therapy has been limited by inefficient gene delivery due 
to the presence of biological barriers for gene transfer, as well as high toxicity and 
immunogenicity.  
Aim: Characteristics of highly efficient, safe, non-toxic, non-immunogenic gene delivery 
based on using novel olygoelectrolyte nanosized polymers. 
Methods: Novel comb-like oligoelectrolyte nanocarriers were synthesized at Lviv 
National Polytechnic University via controlled radical copolymerization using 
oligoperoxide Cu+2 coordinating complexes. Electrophoresis, turbidimetry, MTT assay, 
Ames mutagenicity test were used. Transfection efficiency was determined by 
monitoring Green Fluorescent Protein expression. 
Results: DNA-binding capacity of the polymers was evaluated and the best ones were tested for gene 
delivery. Transfection conditions were optimized. It was found that BG-2 oligoelectrolyte 
possessed 5-7 times higher gene delivery efficiency than other classical transfection 
methods. BG-2 was efficient in crossing cellular barriers due to high lipophilic activity 
and forming stable and small sized complexes with DNA. We observed that DNA was 
completely protected by BG-2 from the action of nucleases. The nanocarrier 
demonstrated low cytotoxicity and no mutagenic potencial towards treated cells. 
Conclusions: Novel DMAEM-based olygoelectrolyte nanosized polymers are 
perspective for the use as nonviral gene delivery vectors. They are non-toxic and non-
mutagenic. Their application is handy and time saving.  
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Aim: Synthesis of poly(N,N′-dimethylacrylamide) (PDMAAm)-coated -Fe2O3 core-shell 
nanoparticles (NPs) by „grafting from” method and their use for mammalian cell labeling. 
Methods: Superparamagnetic maghemite (-Fe2O3) nanoparticles were synthesized by co-
precipitation of FeCl2 and FeCl3 with ammonium hydroxide that was followed by oxidation of 
magnetite with sodium hypochlorite. Surface of -Fe2O3 nanoparticles was functionalized by 
three different initiators [2,2'–azobis (2-methylpropionamidine) dihydrochloride, 4-cyano-4-{[2-
cyano-3-(N-hydroxycarbamoyl)-2-methylpropyl]azo}pentanoic acid and 2,2'-azobis(N'-hydroxy-
2-methylpropanimidamide)]. “Grafting-from” method was then applied for the attachment of 
PDMAAm on the NP surface. Both uncoated and PDMAAm-coated -Fe2O3 nanoparticles were 
thoroughly characterized by scanning and transmission electron microscopy, Fourier-transform 
infrared spectroscopy (FT-IR), dynamic light scattering, zetasizer, and elemental analysis. 
Murine macrophages of J774.2 line were used as a model to investigate the engulfment of the 
NPs by the cells using light and fluorescence microscopy. Cytotoxicity of the NPs was also 
determined.  
Results: Maghemite NPs ( 9 nm) with a rather narrow size distribution (characterized by 
polydispersity index = 1.24) were synthesized by wet co-precipitation method and oxidation. 
Surface of the -Fe2O3 nanoparticles was functionalized with different initiators whose presence 
was confirmed by FT-IR spectroscopy. Properties of the NPs did not change substantially after 
the functionalization. Further polymerization produced PDMAAm-coated -Fe2O3 nanoparticles. 
While their size in dry state increased to 13-16 nm, the hydrodynamic diameter was also higher 
(200 nm) compared with that of the uncoated NPs (113 nm). The NPs formed a stable colloid in 
aqueous solutions, as documented by the zeta–potential equal -51 mV. PDMAAm-coated -
Fe2O3 nanoparticles were then investigated in the in vitro cell experiments in terms of their 
engulfment by murine macrophages at 30 min, 1 h, 2 h, 3 h, or 24 h of cell culturing. The NPs 
were relatively non-toxic for the cultured cells. Their engulfment was very efficient and already 
after 3 h treatment, a majority of PDMAAm-γ-Fe2O3 nanoparticles was engulfed by the 
macrophages. Effect of the mode of NP modification on cell engulfment is discussed.  
Conclusions: Superparamagnetic NPs were successfully prepared by co-precipitation, and they 
were coated with PDMAAm using „grafting-from” the initiator-functionalized particle approach. 
The PDMAAm γ-Fe2O3 nanoparticles formed a stable aqueous colloid. Cell experiments proved 
that the NPs were not cytotoxic. The PDMAAm--Fe2O3 nanoparticles were very quickly 
engulfed by murine macrophages of J774.2 line. Thus, they show high potential for use in 
diagnostics of phagocytic activity. Delivery of various significant biomedical substances, e.g., 
specific proteins and medicines, by using such NPs can be also anticipated. 
Supported by GA CR P206/12/0381.  
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Aim: In-depth study of molecular mechanisms of anticancer activity of 7 members of 
landomycin (L) family (LA, 11-deoxyLA, LB, 11-deoxyLB, LE, LD, 11-deoxyLD), and 
identification of key motifs in chemical structure that are responsible for their 
antineoplastic potential. 
Methods: Annexin V/propidium iodide staining – for quantitative measurement of 
apoptotic/necrotic cells, DAPI staining – for qualitative analysis of chromatin 
fragmentation, Western-blot analysis and flow cytometry – for cell cycle measurement, 
caspase inhibition assays and Western-blot analysis on a panel of 20 proteins involved in 
apoptosis – for identification of molecular targets of Ls in target cells. 
Results: We found that elimination of C11-OH group in the aglycon structure 
significantly decreased anticancer potential of Ls, and the most drastic difference was 
observed with Ls with 6 sugar residues: while the IC50 of LA is 0.3 µM, the IC50 of 11-
deoxy LA is only 3 µM. All Ls with 11-OH group at the aglycon specifically blocked 
tumor cell progression in G1 phase, in contrast to chemically related anticancer drug 
doxorubicin which caused G2/M block. L-induced G1-block was p21- and p27-
dependent. Deoxy Ls did not possess such specificity. The activation of effector caspase-
7 and cleavage of its substrate PARP-1 took place already in 3 h after starting LE 
treatment of Jurkat T-leukemia cells, while activation of the initiator caspases-2, -8, -9,-
10 and mitochondrial proteins Bid, Bax, AIF, Cytochrome C took place much later – 9-
12 h. We did not find any significant activation of caspase-3 in tumor cells by LE, while 
doxorubicin activated it.  
Conclusions: Key structures in the molecule of landomycins responsible for their 
anticancer activity are three or more saccharide residues in glycosidic chain, mandatory 
terminal residue of L-rhodinose, and presence of C11-OH group in aglycon part. Effector 
caspase-7 is a potential target of landomycins. Such targeting might allow these drugs 
effectively killing tumor cells defective on other apoptotic proteins and, thus, resistant to 
chemotherapy.  
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